Table 1 Baseline clinical characteristics
Characteristics | PRP-after group | PRP-prior group | P value |
|---|---|---|---|
Number of eyes | 28 | 30 | |
Gender (M/F) | 12/16 | 19/11 | 0.118 |
Age of onset (years; mean ± SD) | 54.8 ± 9.1 | 53.5 ± 10.3 | 0.618 |
Type of DM (Type 1/Type 2) | 4/24 | 7/23 | 0.508 |
Duration of DM (years; mean ± SD) | 13.0 ± 5.2 | 13.4 ± 5.3 | 0.756 |
HbA1c (mean ± SD) | 7.4 ± 0.6 | 7.3 ± 0.5 | 0.510 |
Presence of hypertension | 11/17 | 12/18 | 0.956 |
Treatment regimen (no insulin/insulin) | 6/22 | 8/22 | 0.641 |
DR severity (Severe NPDR/PDR) | 17/11 | 14/16 | 0.284 |
Preoperative BCVA (LogMAR) | 0.88 ± 0.30 | 0.80 ± 0.27 | 0.286 |
Preoperative CSMT (μm) | 358.75 ± 98.70 | 389.27 ± 137.25 | 0.338 |
EZ (Intact/Disrupted) | 10/18 | 13/17 | 0.553 |